ArticleCancer cell international2026

FGD3 as a prognostic and immunological biomarker: a pan-cancer analysis of its role in tumor progression and the immune landscape.

Jing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.